1.Wong M C S, Jiang J Y, Goggins W B, et al. International incidence and mortality trends of liver cancer: a global profile[J]. Scientific reports, 2017, 7: 45846.
2.Zhang Y, Zheng T, Zhang W. Report of cancer incidence and mortality in China, 2012[J]. Advances in Modern Oncology Research, 2018, 4(3): 1-7.
3.Akinyemiju T, Abera S, Ahmed M, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015[J]. JAMA oncology, 2017, 3(12): 1683-1691.
4.Fu J, Wang H. Precision diagnosis and treatment of liver cancer in China[J]. Cancer letters, 2018, 412: 283-288.
5.Beal E W, Tumin D, Kabir A, et al. Trends in the mortality of hepatocellular carcinoma in the United States[J]. Journal of Gastrointestinal Surgery, 2017, 21(12): 2033-2038.
6.Yu L X, Schwabe R F. The gut microbiome and liver cancer: mechanisms and clinical translation[J]. Nature reviews Gastroenterology & hepatology, 2017, 14(9): 527.
7.Tang W, Wan S, Yang Z, et al. Tumor origin detection with tissue-specific miRNA and DNA methylation markers[J]. Bioinformatics, 2017, 34(3): 398-406.
8.Bavelloni A, Ramazzotti G, Poli A, et al. MiRNA-210: a current overview[J]. Anticancer research, 2017, 37(12): 6511-6521.
9.Vishnoi A, Rani S. MiRNA biogenesis and regulation of diseases: an overview[M]//MicroRNA Profiling. Humana Press, New York, NY, 2017: 1-10.
10.Ye L, Jiang T, Shao H, et al. miR-1290 is a biomarker in DNA-mismatch-repair-deficient colon cancer and promotes resistance to 5-fluorouracil by directly targeting hMSH2[J]. Molecular Therapy-Nucleic Acids, 2017, 7: 453-464.
11.Ma Q, Wang Y, Zhang H, et al. MiR-1290 contributes to colorectal cancer cell proliferation by targeting INPP4B[J]. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 2018, 26(8): 1167-1174.
12.Wang J, Kainrad N, Shen H, et al. Hepatic knockdown of splicing regulator Slu7 ameliorates inflammation and attenuates liver injury in ethanol-fed mice[J]. The American journal of pathology, 2018, 188(8): 1807-1819.
13.Jimenez M, Urtasun R, Elizalde M, et al. SLU7 is a survival factor for cancer cells working as a mitotic regulator[J]. Journal of Hepatology, 2017, 66(1): S645.
14.Nio K, Yamashita T, Kaneko S. The evolving concept of liver cancer stem cells[J]. Molecular cancer, 2017, 16(1): 4.
15.Simonian M, Mosallayi M, Mirzaei H. Circulating miR-21 as novel biomarker in gastric cancer: diagnostic and prognostic biomarker[J]. Journal of cancer research and therapeutics, 2018, 14(2).
16.Han P, Li J, Zhang B, et al. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling[J]. Molecular cancer, 2017, 16(1): 9.
17.Pan J Y, Zhang F, Sun C C, et al. miR-134: a human cancer suppressor?[J]. Molecular Therapy-Nucleic Acids, 2017, 6: 140-149.
18.Liu X, Li J, Yu Z, et al. MiR-935 promotes liver cancer cell proliferation and migration by targeting SOX7[J]. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 2017, 25(3): 427-435.
19.Sandbothe M, Buurman R, Reich N, et al. The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4[J]. Journal of hepatology, 2017, 66(5): 1012-1021.
20.Soung Y, Ford S, Zhang V, et al. Exosomes in cancer diagnostics[J]. Cancers, 2017, 9(1): 8.
21.Barile L, Vassalli G. Exosomes: Therapy delivery tools and biomarkers of diseases[J]. Pharmacology & therapeutics, 2017, 174: 63-78.
22.Kobayashi M, Kenjiro S, Akihiko Y, et al. Elevated level of serum miR-1290 is correlated with high-grade serous ovarian epithelial ovarian cancer and might be a potential biomarker[J]. 2018.
23.Urtasun R, Elizalde M, Azkona M, et al. Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression[J]. Oncogene, 2016, 35(36): 4719.
24.Yan L, Cai K, Sun K, et al. MiR‐1290 promotes proliferation, migration, and invasion of glioma cells by targeting LHX6[J]. Journal of cellular physiology, 2018, 233(10): 6621-6629.
25.Ma Q, Wang Y, Zhang H, et al. MiR-1290 contributes to colorectal cancer cell proliferation by targeting INPP4B[J]. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 2018, 26(8): 1167-1174.